Pulmonary fibrosis is noted with which of the following drugs?
Which drugs can cause fetal renal anomalies?
Methanol primarily affects which cells in the retina?
Peripheral neuropathy is caused by all EXCEPT?
Which drug is known to cause phocomelia?
Which of the following drugs does NOT cause hemolysis?
Tacrolimus belongs to which class of drug?
Succinylcholine is used with caution in all of the following conditions except?
What is the drug of choice for pregnant women with Wilson's disease?
Which of the following drugs can result in cyanide poisoning?
Explanation: **Explanation:** The question asks to identify which drug is associated with pulmonary fibrosis. However, there appears to be a discrepancy in the provided key: **Bumetanide is NOT typically associated with pulmonary fibrosis.** In clinical pharmacology, the classic triad of drugs causing drug-induced interstitial lung disease (DILD) or pulmonary fibrosis includes **Busulfan, Bleomycin, and Amiodarone.** **Analysis of Options:** * **A. Busulfan:** A classic alkylating agent used in chronic myeloid leukemia (CML) and bone marrow conditioning. It is notorious for causing "Busulfan Lung" (interstitial pulmonary fibrosis). * **B. Bleomycin:** A cytotoxic antibiotic used in Hodgkin lymphoma and testicular cancer. It causes dose-dependent pulmonary fibrosis due to oxidative stress and a lack of the inactivating enzyme (bleomycin hydrolase) in the lungs. * **C. Nitrofurantoin:** An antibiotic used for UTIs. Chronic use is a well-known cause of hypersensitivity pneumonitis and progressive pulmonary fibrosis. * **D. Bumetanide (Marked Correct):** This is a **Loop Diuretic** (similar to Furosemide). Its primary side effects are hypokalemia, hyperuricemia, and ototoxicity. It is actually used to *treat* pulmonary edema, not cause fibrosis. **Note on the Answer Key:** In standard medical literature, Options A, B, and C are all correct causes of pulmonary fibrosis. If this is from a specific mock exam where D is marked correct, it is likely a typographical error in the source material. **High-Yield NEET-PG Pearls:** * **Mnemonic for Pulmonary Fibrosis:** "**BBAT**" – **B**leomycin, **B**usulfan, **A**miodarone, **T**oxic (Nitrofurantoin/Methotrexate). * **Bleomycin:** Monitor with DLCO (Diffusion capacity of the lung for carbon monoxide); toxicity increases if cumulative dose exceeds 400 units. * **Amiodarone:** Contains iodine; causes "foamy macrophages" in airspaces and can lead to fatal fibrosis. * **Methotrexate:** Causes acute pneumonitis more commonly than chronic fibrosis.
Explanation: **Explanation:** **Correct Answer: C. Losartan** **Mechanism and Concept:** Losartan is an **Angiotensin II Receptor Blocker (ARB)**. Both ACE inhibitors (e.g., Enalapril) and ARBs (e.g., Losartan) are strictly contraindicated in the second and third trimesters of pregnancy. They interfere with the fetal **Renin-Angiotensin-Aldosterone System (RAAS)**, which is essential for normal fetal renal development and function. Blockade of RAAS leads to **fetal hypotension and reduced renal perfusion**, resulting in: * **Fetal Renal Dysgenesis/Anomalies:** Failure of kidneys to develop properly. * **Oligohydramnios:** Reduced amniotic fluid due to decreased fetal urine output. * **Potter’s Sequence:** Secondary to oligohydramnios, leading to cranial deformities, limb contractures, and pulmonary hypoplasia. **Analysis of Incorrect Options:** * **A. Nifedipine:** A Calcium Channel Blocker (CCB) used as a first-line agent for gestational hypertension and as a tocolytic. It is generally considered safe in pregnancy. * **B. Furosemide:** A loop diuretic. While generally avoided unless necessary (as it may reduce placental perfusion), it is not specifically associated with fetal renal structural anomalies. * **D. Prazosin:** An alpha-1 blocker. It is not a first-line agent but is not known to cause fetal renal dysgenesis. **High-Yield Clinical Pearls for NEET-PG:** * **Safe Antihypertensives in Pregnancy:** Remember the mnemonic **"Better Mother Care During Hypertensive"** episodes: **B**e-blockers (Labetalol - Drug of Choice), **M**ethyldopa (Classic DOC), **C**alcium Channel Blockers (Nifedipine), **D**ihydralazine. * **ACEi/ARBs Teratogenicity:** Specifically associated with **hypocalvaria** (incomplete ossification of skull bones) and renal failure. * **Critical Period:** RAAS inhibitors are most damaging during the **2nd and 3rd trimesters** (organogenesis is mostly complete, but functional development of kidneys is ongoing).
Explanation: Methanol (wood alcohol) toxicity is a high-yield topic in NEET-PG, primarily characterized by metabolic acidosis and specific ocular damage [1]. **Why Ganglion Cells are the Correct Answer:** The toxicity of methanol is not due to the alcohol itself, but its metabolite, **formic acid** (formed via alcohol dehydrogenase and aldehyde dehydrogenase) [2]. Formic acid acts as a mitochondrial toxin by inhibiting the enzyme **cytochrome c oxidase** in the electron transport chain. This leads to "histotoxic hypoxia" at the cellular level. The **retinal ganglion cells** and the **optic nerve** are exceptionally sensitive to this disruption of oxidative phosphorylation. The resulting damage leads to retinal edema, degeneration of ganglion cells, and eventually optic atrophy, clinically manifesting as "snowstorm vision" or complete blindness. **Analysis of Incorrect Options:** * **A & B (Cones and Rods):** While methanol affects the overall retinal environment, the primary and most significant site of permanent pathological damage is the ganglion cell layer and the retrobulbar optic nerve, rather than the photoreceptors (rods and cones). * **D (Germinal cell layer):** This layer is involved in cell proliferation (e.g., in the lens or during development) and is not the target of formic acid toxicity. **Clinical Pearls for NEET-PG:** * **Antidote of choice:** **Fomepizole** (inhibits alcohol dehydrogenase) [2]. Ethanol is used as an alternative if fomepizole is unavailable [2]. * **Classic Presentation:** High anion gap metabolic acidosis (HAGMA) with an increased osmolar gap. * **Putaminal Necrosis:** On MRI, bilateral necrosis of the putamen is a pathognomonic finding of methanol poisoning. * **Treatment Adjunct:** **Folic acid** (leucovorin) is administered to enhance the degradation of formic acid into carbon dioxide and water.
Explanation: **Explanation:** The correct answer is **Digitalis (Option B)**. Digitalis (Digoxin) toxicity is primarily characterized by gastrointestinal symptoms (nausea, vomiting), cardiac arrhythmias, and neurological symptoms such as blurred vision, xanthopsia (yellow-green halos), and confusion. It does **not** cause peripheral neuropathy. **Analysis of Options:** * **Isoniazid (INH):** A classic cause of peripheral neuropathy. It inhibits the enzyme pyridoxine kinase, leading to a deficiency of Vitamin B6 (Pyridoxine). This is why B6 is co-administered with INH in antitubercular therapy. * **Amiodarone:** This Class III antiarrhythmic drug is known for a wide range of toxicities. Chronic use can lead to peripheral neuropathy, along with pulmonary fibrosis, thyroid dysfunction, and corneal microdeposits. * **Tolbutamide:** A first-generation sulfonylurea. While less common than with newer drugs, sulfonylureas have been documented to cause peripheral neuropathy as a rare side effect. **NEET-PG High-Yield Pearls:** * **Mnemonic for Drugs causing Peripheral Neuropathy:** "**S**ome **H**ighly **P**oisonous **D**rugs **C**ause **V**ery **I**ntense **N**umbness" (**S**alvage/Stavudine, **H**ydralazine, **P**henytoin, **D**isulfiram, **C**isplatin, **V**incristine, **I**soniazid, **N**itrofurantoin). * **Vincristine:** Causes "stocking and glove" neuropathy and is notorious for autonomic neuropathy (constipation/paralytic ileus). * **Ethambutol:** Primarily causes optic neuritis (red-green color blindness), not peripheral neuropathy. * **Digitalis Toxicity:** The most common ECG finding is PVCs; the most characteristic is Paroxysmal Atrial Tachycardia with AV block.
Explanation: **Explanation:** **Thalidomide** is the classic teratogen associated with **phocomelia** (seal-like limbs), a condition characterized by the direct attachment of hands or feet to the trunk due to the failure of long bone development. Originally marketed in the late 1950s as a sedative and anti-emetic for morning sickness, it led to a global tragedy involving thousands of birth defects. The mechanism involves the inhibition of angiogenesis and interference with the protein **Cereblon**, which is essential for limb bud development. **Analysis of Incorrect Options:** * **Phenytoin:** Causes **Fetal Hydantoin Syndrome**, characterized by hypoplastic nails and phalanges, craniofacial dysmorphism (cleft lip/palate), and microcephaly. * **Alcohol:** Leads to **Fetal Alcohol Syndrome (FAS)**, the most common cause of preventable intellectual disability. Key features include maxillary hypoplasia, smooth philtrum, thin upper lip, and short palpebral fissures. * **Lithium:** Associated with **Ebstein’s Anomaly**, a cardiac defect involving the downward displacement of the tricuspid valve leaflets into the right ventricle. **High-Yield Clinical Pearls for NEET-PG:** * **Current Uses of Thalidomide:** Despite its history, it is now a first-line treatment for **Multiple Myeloma** and **Erythema Nodosum Leprosum (ENL)**. * **Critical Period:** The risk for phocomelia is highest if taken between the **24th and 36th day** of gestation. * **Warfarin:** Causes **Fetal Warfarin Syndrome** (stippled epiphyses and nasal hypoplasia). * **Valproate:** Highest risk for **Neural Tube Defects** (Spina Bifida).
Explanation: ### Explanation The core concept behind this question is **Drug-Induced Hemolysis in G6PD Deficiency**. Glucose-6-Phosphate Dehydrogenase (G6PD) is an enzyme essential for maintaining levels of reduced glutathione, which protects red blood cells (RBCs) from oxidative stress. Drugs that act as oxidizing agents can cause hemoglobin to precipitate (forming Heinz bodies), leading to hemolysis in G6PD-deficient individuals. **Why Chloroquine is the correct answer:** While **Chloroquine** is an antimalarial, it is considered **safe** and does not typically cause hemolysis in G6PD-deficient patients at standard doses. It lacks the potent oxidizing potential required to trigger an erythrocyte crisis. **Analysis of Incorrect Options:** * **Primaquine (B):** This is the classic "textbook" trigger for G6PD-related hemolysis. It is an 8-aminoquinoline that generates significant reactive oxygen species (ROS). * **Nalidixic acid (C):** A first-generation quinolone antibiotic known to be a potent oxidizing agent capable of inducing hemolytic anemia. * **Nitrofurantoin (D):** Commonly used for UTIs, this drug is a well-documented oxidative stressor and is strictly contraindicated in patients with known G6PD deficiency. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for G6PD Triggers:** "**AAA**" – **A**ntimalarials (Primaquine), **A**ntibiotics (Sulfonamides, Nitrofurantoin, Quinolones), and **A**nalgesics (Aspirin - high dose). * **Other Triggers:** Fava beans (Favism), Dapsone, and infections (most common cause). * **Safe Alternatives:** Chloroquine, Quinine, and Paracetamol (at normal doses) are generally safe. * **Peripheral Smear Finding:** Look for **"Bite cells"** (degmacytes) and **Heinz bodies** (denatured hemoglobin).
Explanation: **Explanation:** **Tacrolimus** is a potent immunosuppressant primarily used to prevent organ transplant rejection. It belongs to the **Calcineurin Inhibitor (CNI)** class. **1. Why Calcineurin Inhibitor is Correct:** Tacrolimus (also known as FK-506) binds to an intracellular protein called **FK-binding protein (FKBP-12)**. This complex then inhibits **calcineurin**, a phosphatase responsible for dephosphorylating the Nuclear Factor of Activated T-cells (NFAT). By preventing this dephosphorylation, NFAT cannot enter the nucleus to promote the transcription of **Interleukin-2 (IL-2)**. Without IL-2, T-cell activation and proliferation are suppressed. **2. Analysis of Incorrect Options:** * **mTOR Inhibitors:** This class includes **Sirolimus (Rapamycin)** and Everolimus. While they also bind to FKBP-12, they inhibit the "mammalian Target of Rapamycin" (mTOR) rather than calcineurin, blocking the cell cycle in the G1-S phase. * **Hypoxanthine/Inosine Inhibitors:** These refer to drugs like **Mycophenolate Mofetil (MMF)**, which inhibits **Inosine Monophosphate Dehydrogenase (IMPDH)**. This blocks the *de novo* synthesis of guanosine nucleotides, specifically affecting lymphocyte proliferation. **3. High-Yield Clinical Pearls for NEET-PG:** * **Comparison with Cyclosporine:** Both are CNIs, but Cyclosporine binds to **Cyclophilin**, whereas Tacrolimus binds to **FKBP**. * **Side Effects:** Tacrolimus is more likely to cause **Post-Transplant Diabetes Mellitus (PTDM)** and neurotoxicity, whereas Cyclosporine is more associated with **gingival hyperplasia** and **hirsutism**. Both cause nephrotoxicity. * **Drug of Choice:** Tacrolimus is generally preferred over Cyclosporine due to its higher potency and better rejection-prevention profile.
Explanation: **Explanation:** Succinylcholine (SCh) is a depolarizing neuromuscular blocker that acts as an agonist at the nicotinic acetylcholine receptors (nAChR). The correct answer is **Tachycardia** because SCh typically causes **bradycardia** (especially in children or with repeat doses) due to its structural similarity to acetylcholine, which stimulates cardiac muscarinic receptors. It does not exacerbate tachycardia; in fact, it is not contraindicated in tachycardic patients. **Why the other options are wrong (Contraindications for SCh):** * **Burns and Crush Injuries:** These conditions lead to "upregulation" of extrajunctional acetylcholine receptors. When SCh depolarizes these widespread receptors, there is a massive efflux of potassium from the cells. This can lead to **severe hyperkalemia**, resulting in cardiac arrest. This risk is highest from 24 hours to several months post-injury. * **Myasthenia Gravis (MG):** Patients with MG have a reduced number of functional nAChRs. While they are resistant to SCh, the response is unpredictable. More importantly, they may develop a **Phase II block** (dual block) even with standard doses, leading to prolonged and dangerous respiratory paralysis. **Clinical Pearls for NEET-PG:** * **Drug of Choice:** SCh remains the drug of choice for **Rapid Sequence Induction (RSI)** due to its rapid onset (30-60s) and short duration (5-10 mins). * **Metabolism:** It is metabolized by **Pseudocholinesterase** (Plasma cholinesterase). Deficiency of this enzyme leads to prolonged apnea. * **Malignant Hyperthermia:** SCh is a known trigger for Malignant Hyperthermia (Treatment: Dantrolene). * **Side Effects:** Muscle fasciculations (can cause post-op myalgia), increased intraocular, intragastric, and intracranial pressure.
Explanation: **Explanation:** **Why Zinc is the Correct Answer:** Zinc is considered the drug of choice for managing Wilson’s disease during pregnancy. Its mechanism involves inducing **metallothionein** in intestinal mucosal cells, which acts as an intracellular ligand that binds copper and prevents its absorption into the systemic circulation. Zinc is preferred in pregnancy because it is **non-teratogenic** and has a superior safety profile compared to chelating agents. Maintaining copper balance is crucial during pregnancy, as both untreated Wilson’s disease and over-treatment (copper deficiency) can lead to adverse fetal outcomes. **Analysis of Incorrect Options:** * **B. Penicillamine:** While it is a potent copper chelator, it is associated with **teratogenicity** (specifically cutis laxa and connective tissue defects in the fetus). If used, the dose must be strictly reduced to the minimum effective amount to allow for fetal development. * **D. Trientine:** This is a second-line chelating agent. While it is generally safer than Penicillamine, it is still a chelator and is typically reserved for patients who cannot tolerate Zinc or have high disease activity. * **C. Molybdenum:** Tetrathiomolybdate is an experimental agent used primarily for the initial neurological presentation of Wilson’s disease; it is not a standard treatment for maintenance, especially during pregnancy. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Zinc:** Induces metallothionein (High-yield MCQ point). * **Dose Adjustment:** In pregnant patients on chelators (Penicillamine/Trientine), doses are often reduced by 25-50% in the last trimester to ensure adequate copper for fetal growth and wound healing (post-delivery). * **Breastfeeding:** Zinc is safe during breastfeeding, whereas Penicillamine is generally avoided. * **Diagnosis:** Look for low serum ceruloplasmin, increased urinary copper, and Kayser-Fleischer (KF) rings on slit-lamp exam.
Explanation: ### Explanation **Correct Option: A. Sodium Nitroprusside** Sodium Nitroprusside (SNP) is a potent vasodilator used in hypertensive emergencies. Its chemical structure contains five cyanide groups. When SNP enters the bloodstream, it reacts with hemoglobin to release **nitric oxide** (the active vasodilator) and **cyanide ions**. Normally, the liver enzyme **rhodanese** detoxifies cyanide by converting it to thiocyanate. However, prolonged infusion or high doses can overwhelm this system, leading to cyanide toxicity. Cyanide inhibits **cytochrome oxidase (Complex IV)** in the electron transport chain, causing cellular hypoxia and metabolic acidosis. **Incorrect Options:** * **B. Amyl nitrite:** This is actually an **antidote** for cyanide poisoning. It induces the formation of methemoglobin, which has a high affinity for cyanide, pulling it away from cytochrome oxidase to form cyanmethemoglobin. * **C. Hydroxycobalamin:** This is the **preferred first-line treatment** for cyanide poisoning. It combines with cyanide to form non-toxic **cyanocobalamin** (Vitamin B12), which is excreted by the kidneys. * **D. Sodium thiosulphate:** This is a **cyanide antidote** that acts as a sulfur donor. It assists the enzyme rhodanese in converting toxic cyanide into the less toxic, excretable thiocyanate. **High-Yield Clinical Pearls for NEET-PG:** * **Classic Presentation:** A patient on SNP infusion developing unexplained metabolic (lactic) acidosis, "cherry-red" skin, and an almond-like odor on the breath. * **Management Sequence:** 1. Hydroxycobalamin (First-line) OR 2. Amyl nitrite/Sodium nitrite (to create methemoglobin) followed by Sodium thiosulphate. * **Toxicity Risk:** Risk increases in patients with renal or hepatic impairment. Monitoring thiocyanate levels is recommended if SNP is used for >48 hours.
Principles of Clinical Pharmacology
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Drug Toxicity and Overdose
Practice Questions
Antidotes and Their Applications
Practice Questions
Management of Drug Poisoning
Practice Questions
Drug-Induced Liver Injury
Practice Questions
Drug-Induced Kidney Injury
Practice Questions
Drug-Induced Blood Dyscrasias
Practice Questions
Drug-Induced QT Prolongation
Practice Questions
Pharmacovigilance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free